This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
Let’s admit it. We’re all fascinated by the stock market’s hot stocks, aren’t we? That doesn’t mean we’re adrenaline junkies hopping from bandwagon to bandwagon. But it can be mesmerizing to see a stock double, triple or quadruple in a short period of time.
RIOT FB VRX AMZN GOOGL TSLA NFLX NYTAB GOOG FOSL BIOP BHC
Target Corporation (TGT - Free Report) announced that it has recorded the highest online one-day traffic and sales this year on Jul 17. The massive sales were primarily backed by a one-day sale on the company’s exclusive and national brands, which coincided with Amazon’s (AMZN - Free Report) Prime Day.
TGT URBN FOSL
The Children's Place, Inc.’s (PLCE - Free Report) shares have not only declined year to date but also underperformed its industry and the broader market. The stock has declined around 18% against the industry’s growth of 0.2% and the S&P 500’s increase of 5% in the same time frame.
BURL SCVL FOSL PLCE
Shares of Urban Outfitters, Inc. (URBN - Free Report) have risen around 31% year to date, outperforming the industry’s gain of 0.2% and the overall sector’s 13.4%. We believe new store openings, increased digital penetration, merchandising improvement and international expansion bode well. Management is also making all possible efforts to enhance the performance of brands through store refurbishment and by bringing in more compelling assortments.
BURL SCVL URBN FOSL
Signet Jewelers Limited (SIG - Free Report) recently announced initiatives under the ‘Signet Path to Brilliance’ plan for the next three years. Notably, the plan primarily focuses on bringing about cost effectiveness.
SIG SCVL VEEV URBN FOSL SGH SIG
Dollar General Corporation (DG - Free Report) recently announced the opening of its 15000th store in Wilmington, NC. Notably, this discount retailer has grown as a reliable partner for many communities across 44 states, which includes 800 stores in North Carolina.
POOL GTT SCVL DG URBN FOSL
Shares of wearables maker Fitbit (NYSE:FIT) were red-hot in May and early June. FIT stock rallied from $4 to $8 on renewed optimism regarding the company’s pivot into smartwatches. Investors were also getting excited about the company’s long-term growth prospects through enterprise data partnerships.
FB FIT GOOGL AAPL NYTAB GOOG FOSL SNAP
There seems to be no respite for L Brands, Inc. (LB - Free Report) , which slipped 12.1% following the release of its June 2018 sales results. This is because comparable sales (comps) fell 1% at Victoria’s Secret despite an extended sale and slashed prices.
SCVL LB URBN FOSL SAM
Among the retailers and brands that could be most impacted from the proposed 10% tariffs on $200 billion in Chinese goods are Best Buy Co. Inc., Michael Kors Holdings Ltd., and Coach parent Tapestry Inc., say analysts.
WFC CHOO WFCNP WFC.WS BURL WFC.PRL WFC.PRJ JYMHF FOSL WFC.PRT DLTR WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN KORS DG KATE WFC.PRY WFC.PRX WFC.PRW WFC.PRV
Shares of Sally Beauty Holdings, Inc. (SBH - Free Report) have not only declined, but also underperformed the industry and the overall sector in the past three months. This Zacks Rank #4 (Sell) stock lost 1.1% against the industry’s growth of 13.7% and overall sector’s increase of 10.6%, courtesy of the decline in comps and contraction in margins. Apart from these, the trimmed guidance for fiscal 2018 also hurt investors’ sentiments.
SCVL SBH URBN FOSL
Fossil Group, Inc. (FOSL - Free Report) has been nothing less than a gold mine for investors since the beginning of 2018. Well, shares of this renowned watchmaker more than tripled in the past six months compared with the industry’s rise of 5.7%. So, what’s boosting investors’ optimism for this Zacks Rank #2 (Buy) stock? Let’s take a look. Wearables Offer Growth Impetus Fossil owes much of its success to the stupendous growth in connected wearables category.
URBN FOSL VRA
Dollar General Corporation’s (DG - Free Report) solid prospects, brand recognition and earnings outlook bode well for the stock. The company’s commitment toward better pricing, private label offering, effective inventory management, and merchandise and operational initiatives should drive sales and margins. These along with a compelling store growth story at convenient locations and focus on consumable products provide the company an edge over competitors.
BURL DG URBN FOSL
Technology has been playing a major role in shaping the retail landscape. Retailers are fast adopting the omni-channel mantra to provide a seamless shopping experience, online and at stores. To keep up with the altering scenario, Burlington Stores, Inc. (BURL - Free Report) has made multiple changes to its business model. Further, in order to drive the top line, this company has been focusing on store expansion.
BURL SCVL CVRR URBN FOSL
Foot Locker, Inc. (FL - Free Report) has managed to pull off a decent run in the past six months amid the prevailing headwinds in the retail sector. Shares of this company have gained nearly 13% in the past six months, notably outperforming the industry, which grew 9.5%. Also, this Zacks Rank #3 (Hold) stock has comfortably outpaced the broader Retail - Wholesale sector's growth of just 6.2% in the said time period.
SCVL CVRR FL URBN FOSL
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to FOSL / Fossil Group, Inc. on message board site Silicon Investor.
|CAMP, FOSL, ZLC, CSCC, Articles||Fossil(FOSL)|
as of ET